SG11201806985WA - Methods and reagents for prevention and/or treatment of infection - Google Patents
Methods and reagents for prevention and/or treatment of infectionInfo
- Publication number
- SG11201806985WA SG11201806985WA SG11201806985WA SG11201806985WA SG11201806985WA SG 11201806985W A SG11201806985W A SG 11201806985WA SG 11201806985W A SG11201806985W A SG 11201806985WA SG 11201806985W A SG11201806985W A SG 11201806985WA SG 11201806985W A SG11201806985W A SG 11201806985WA
- Authority
- SG
- Singapore
- Prior art keywords
- hospitalet
- international
- reynals
- idibell
- llobregat
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 5
- XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 abstract 4
- 239000005293 duran Substances 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 102220240796 rs553605556 Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14382324.3A EP2987503A1 (en) | 2014-08-22 | 2014-08-22 | Methods and reagents for prevention and/or treatment of infection |
| PCT/EP2015/069334 WO2016026981A1 (en) | 2014-08-22 | 2015-08-24 | Methods and reagents for prevention and/or treatment of infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201806985WA true SG11201806985WA (en) | 2018-09-27 |
Family
ID=51485539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201806985WA SG11201806985WA (en) | 2014-08-22 | 2015-08-24 | Methods and reagents for prevention and/or treatment of infection |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP2987503A1 (pl) |
| JP (1) | JP6612346B2 (pl) |
| KR (1) | KR102492850B1 (pl) |
| CN (1) | CN107073020B (pl) |
| AU (1) | AU2015305108B2 (pl) |
| CA (1) | CA2958600C (pl) |
| ES (1) | ES2759565T3 (pl) |
| MX (1) | MX378754B (pl) |
| PL (1) | PL3183003T3 (pl) |
| RU (1) | RU2698099C2 (pl) |
| SG (1) | SG11201806985WA (pl) |
| WO (1) | WO2016026981A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3707193A1 (en) * | 2017-11-10 | 2020-09-16 | The Johns Hopkins University | Dendrimer delivery system and methods of use thereof |
| CN108646029B (zh) * | 2018-05-14 | 2021-07-02 | 中国食品药品检定研究院 | 人抗-Gal-IgG抗体检测试剂盒及其制备方法和用途 |
| CN112514118A (zh) * | 2018-07-31 | 2021-03-16 | 住友金属矿山株式会社 | 锂离子二次电池用正极活性物质、锂离子二次电池用正极活性物质的制造方法以及锂离子二次电池 |
| EP3964235A1 (en) * | 2020-09-08 | 2022-03-09 | RemAb Therapeutics SL | Glycoconjugates and medical uses thereof |
| WO2023138211A1 (zh) * | 2022-01-21 | 2023-07-27 | 苏州万维生命科学技术有限公司 | 星型β-抗菌糖肽、其制备方法及应用 |
| CN116515102B (zh) * | 2022-01-21 | 2025-04-18 | 苏州万维生命科学技术有限公司 | 星型β-抗菌糖肽、其制备方法及应用 |
| US20240123420A1 (en) * | 2022-10-12 | 2024-04-18 | Kelly Nicholson | Furnace for endothermic processes |
| CN117269514A (zh) * | 2022-10-18 | 2023-12-22 | 天津德祥生物技术股份有限公司 | 一种血型抗原三糖a类似物蛋白偶联物及应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0089940A1 (en) * | 1982-03-23 | 1983-09-28 | BioCarp AB | Compositions for therapeutic or diagnostic use containing oligosaccharides |
| US5262165A (en) | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
| US6010715A (en) | 1992-04-01 | 2000-01-04 | Bertek, Inc. | Transdermal patch incorporating a polymer film incorporated with an active agent |
| AUPM623994A0 (en) * | 1994-06-15 | 1994-07-07 | Biomolecular Research Institute Limited | Antiviral dendrimers |
| HU228434B1 (en) | 1995-06-07 | 2013-03-28 | Ortho Mcneil Pharm Inc | Transdermal medicament for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| DE69835201T2 (de) | 1997-04-18 | 2007-06-14 | Novartis Ag | Neoglycoproteine |
| US5948433A (en) | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
| ATE304865T1 (de) * | 1998-04-15 | 2005-10-15 | Mayo Foundation | Hemmung xenoreaktiver antikörper |
| IL150410A0 (en) * | 2000-01-13 | 2002-12-01 | Alchemia Pty Ltd | METHODS FOR SYNTHESIS OF α-D-GAL (1-3) GAL-CONTAINING OLIGOSACCHARIDES |
| CA2514270A1 (en) * | 2003-02-06 | 2004-08-19 | Tripep Ab | Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| AU2003901008A0 (en) | 2003-03-04 | 2003-03-20 | Anadis Ltd | Composition for the treatment and prevention of bacterial infections |
| US7915235B2 (en) * | 2006-03-20 | 2011-03-29 | Brian Dieckgraefe | High affinity ligands bind to clostridium difficile toxin A |
| US8361441B2 (en) | 2008-03-11 | 2013-01-29 | Taipei Medical University | Detection and therapy of bacterial infection caused by Enterobacteriaceae |
| US7928077B2 (en) * | 2008-07-11 | 2011-04-19 | Academia Sinica | Alpha-galactosyl ceramide analogs and their use as immunotherapies |
-
2014
- 2014-08-22 EP EP14382324.3A patent/EP2987503A1/en not_active Withdrawn
-
2015
- 2015-08-24 RU RU2017108569A patent/RU2698099C2/ru active
- 2015-08-24 PL PL15751042T patent/PL3183003T3/pl unknown
- 2015-08-24 EP EP15751042.1A patent/EP3183003B1/en active Active
- 2015-08-24 AU AU2015305108A patent/AU2015305108B2/en active Active
- 2015-08-24 WO PCT/EP2015/069334 patent/WO2016026981A1/en not_active Ceased
- 2015-08-24 CN CN201580049351.4A patent/CN107073020B/zh active Active
- 2015-08-24 CA CA2958600A patent/CA2958600C/en active Active
- 2015-08-24 JP JP2017529149A patent/JP6612346B2/ja active Active
- 2015-08-24 SG SG11201806985WA patent/SG11201806985WA/en unknown
- 2015-08-24 MX MX2017002385A patent/MX378754B/es unknown
- 2015-08-24 KR KR1020177006316A patent/KR102492850B1/ko active Active
- 2015-08-24 ES ES15751042T patent/ES2759565T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3183003B1 (en) | 2019-07-31 |
| EP2987503A1 (en) | 2016-02-24 |
| KR20170043556A (ko) | 2017-04-21 |
| AU2015305108A1 (en) | 2017-04-06 |
| RU2698099C2 (ru) | 2019-08-22 |
| JP2017525763A (ja) | 2017-09-07 |
| RU2017108569A (ru) | 2018-09-24 |
| WO2016026981A1 (en) | 2016-02-25 |
| CA2958600A1 (en) | 2016-02-25 |
| PL3183003T3 (pl) | 2020-03-31 |
| JP6612346B2 (ja) | 2019-11-27 |
| AU2015305108B2 (en) | 2021-03-18 |
| MX2017002385A (es) | 2017-06-30 |
| CA2958600C (en) | 2023-01-10 |
| CN107073020A (zh) | 2017-08-18 |
| KR102492850B1 (ko) | 2023-01-26 |
| RU2017108569A3 (pl) | 2019-03-13 |
| CN107073020B (zh) | 2019-12-10 |
| ES2759565T3 (es) | 2020-05-11 |
| MX378754B (es) | 2025-03-10 |
| EP3183003A1 (en) | 2017-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201806985WA (en) | Methods and reagents for prevention and/or treatment of infection | |
| SG11201907034PA (en) | Methods of treating influenza | |
| SG11201909963YA (en) | Methods for treating dravet syndrome | |
| SG11201906431UA (en) | Method for the treatment of thromboembolism | |
| SG11201407340YA (en) | Treatment of myelosuppression | |
| SG11201804312RA (en) | Microbubble-chemotherapeutic agent complex for sonodynamic therapy | |
| SG11201806868TA (en) | Compositions and methods for protecting against airborne pathogens and irritants | |
| SG11201808539WA (en) | Mouth piece for cooling of oral tissue of a patient during chemotherapy treatment | |
| SG11201803686UA (en) | Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease | |
| SG11201807809XA (en) | A transient commensal microorganism for improving gut health | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201811019TA (en) | Device for cardiac valve repair and method of implanting the same | |
| SG11201811432WA (en) | Rna for cancer therapy | |
| SG11201807913XA (en) | Stabilized soluble pre-fusion rsv f proteins | |
| SG11201408459VA (en) | Purification of virus like particles | |
| SG11201810280YA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201901374WA (en) | Antibiotic compounds | |
| SG11201407110QA (en) | Novel dosage form and formulation of abediterol | |
| SG11201809341PA (en) | Mobile robot | |
| SG11201900021PA (en) | Methods and compositions for the treatment of cancer | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201900551WA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
| SG11201804889XA (en) | Fluid interface device for delivering fluid to and/or withdrawing fluid from a patient |